The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening-Reference-Cited by-同舟云学术

The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening

Published:2021-08-15 Issue: Volume: Page:
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Benafif Sarah¹^ORCID,Ni Raghallaigh Holly¹,McGrowder Eva¹,Saunders Edward J.¹,Brook Mark N.¹,Saya Sibel¹²,Rageevakumar Reshma¹,Wakerell Sarah¹,James Denzil¹,Chamberlain Anthony¹,Taylor Natalie³,Hogben Matthew³,Benton Barbara³,D’Mello Lucia³,Myhill Kathryn³,Mikropoulos Christos⁴,Bowen‐Perkins Hywel⁵,Rafi Imran⁶,Ferris Michelle⁷,Beattie Andre⁸,Kuganolipava Shophia⁹,Sevenoaks Tamsin¹⁰,Bower Juliet¹¹,Kumar Pardeep³,Hazell Steven³,deSouza Nandita M.¹²,Antoniou Antonis¹³,Bancroft Elizabeth¹³^ORCID,Kote‐Jarai Zsofia¹,Eeles Rosalind¹³

Affiliation:

1. Oncogenetics Team Institute of Cancer Research London UK

2. The University of Melbourne Melbourne Victoria Australia

3. Cancer Genetics Unit and Academic Urology Unit Royal Marsden NHS Foundation Trust LondonUK

4. Royal Surrey County Hospital NHS Foundation Trust SurreyUK

5. Shadbolt Park House Surgery Worcester ParkUK

6. The Longcroft Clinic BansteadUK

7. Lane End Medical Group EdgwareUK

8. Dorking Medical Practice Dorking UK

9. Medwyn Surgery Dorking UK

10. Brockwood Medical Practice Dorking UK

11. Leith Hill Practice DorkingUK